FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Gennex Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:531739 P/E (TTM) :18.31
ISIN Demat:INE509C01026 Div & Yield %:0 EPS (TTM) :0.62
Book Value (RS) :7.8732292 Market Cap (Rs Cr.):258.15 Face Value (RS) :1
    Change Company 
Particulars Quarter Ended
(Jun 2025)		 Quarter Ended
(Jun 2024)		 Quarter Ended
(% Var)
Sales 25.64 21.33 20.21
Other Income 2.26 2.46 -8.13
PBIDT 5.64 5.38 4.83
Interest 0.59 0.29 103.45
PBDT 5.05 5.09 -0.79
Depreciation 0.20 0.17 17.65
PBT 4.85 4.92 -1.42
Tax 0.70 0.75 -6.67
Deferred Tax 0.00 0.00 0.00
PAT 4.15 4.17 -0.48

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)